Browsing by Subject
Ara mostrant els elements 1-2 d 2
-
Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial
(American Medical Association, 2023-11)
Ara mostrant els elements 1-2 d 2